Serum adiponectin, interleukin-10 levels and inflammatory markers in the metabolic syndrome

被引:87
作者
Choi, K. M. [1 ]
Ryu, O. H. [1 ]
Lee, K. W. [1 ]
Kim, H. Y. [1 ]
Seo, J. A. [1 ]
Kim, S. G. [1 ]
Kim, N. H. [1 ]
Choi, D. S. [1 ]
Baik, S. H. [1 ]
机构
[1] Korea Univ, Guro Hosp, Dept Internal Med, Div Endocrinol & Metab,Coll Med, Seoul 152050, South Korea
关键词
C-reactive protein; interleukin-6; interleukin-10; adiponectin; metabolic syndrome;
D O I
10.1016/j.diabres.2006.06.019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We examined the association between interleukin-10 (IL-10), adiponectin levels and inflammatory markers such as interleukin-6 (IL-6) and high-sensitive C-reactive protein (hsCRP). Furthermore, the association of these anti-/pro-inflammatory cytokine levels with the metabolic syndrome was investigated. The study subjects were composed of 312 Korean individuals without diabetes. Serum adiponectin level was associated with hsCRP (r = -0.21, P < 0.001), IL-6 (r = -0. 13, P < 0.05) and IL-10 (r = -0.22, P < 0.001) levels. Subjects without the metabolic syndrome showed higher adiponectin (17.03 mu g/ml versus 13.85 mu g/ml, P < 0.001) and IL-10 (4.74 pg/ml versus 4.34 pg/ml, P = 0.014) levels, and lower serum hsCRP (0.38 mu g/ml versus 0.66 mu g/ ml, P = 0.001) and IL-6 (0.94 pg/ml versus 1.32 pg/ml, P = 0.009) levels compared to those with the metabolic syndrome. In multiple logistic regression analysis, the metabolic syndrome was associated with sex, age, waist circumference, systolic blood pressure, HDL cholesterol, triglyceride, fasting blood glucose and interleukin-10. Furthermore, serum adiponectin levels are associated with serum hsCRP, IL-6 and IL-10 levels. These results suggest that adiponectin might be associated with the metabolic syndrome through regulation of pro-/anti-inflammatory cytokines. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:235 / 240
页数:6
相关论文
共 30 条
  • [21] ROLE OF INSULIN RESISTANCE IN HUMAN-DISEASE
    REAVEN, GM
    [J]. DIABETES, 1988, 37 (12) : 1595 - 1607
  • [22] C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
    Ridker, PM
    Hennekens, CH
    Buring, JE
    Rifai, N
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (12) : 836 - 843
  • [23] Mechanisms of disease - Atherosclerosis - An inflammatory disease
    Ross, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (02) : 115 - 126
  • [24] Anti-inflammatory mechanisms in the vascular wall
    Tedgui, A
    Mallat, Z
    [J]. CIRCULATION RESEARCH, 2001, 88 (09) : 877 - 887
  • [25] Interleukin-10: an anti-atherogenic cytokine?
    Tedgui, A
    Mallat, Z
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2001, 31 (01) : 1 - 2
  • [26] Inflammation and stroke -: The Leiden 85-plus study
    van Exel, E
    Gussekloo, J
    de Craen, AJM
    Bootsma-van der Wiel, A
    Frölich, M
    Westendorp, RGJ
    [J]. STROKE, 2002, 33 (04) : 1135 - 1138
  • [27] Low production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes -: The Leiden 85-plus study
    van Exel, E
    Gussekloo, J
    de Craen, AJM
    Frölich, M
    Bootsma-van der Wiel, A
    Westendorp, RGJ
    [J]. DIABETES, 2002, 51 (04) : 1088 - 1092
  • [28] Wakkach A, 2000, EUR CYTOKINE NETW, V11, P153
  • [29] *WHO, 2002, AS PAC PERSP DEF OB
  • [30] Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?
    Yudkin, JS
    Kumari, M
    Humphries, SE
    Mohamed-Ali, V
    [J]. ATHEROSCLEROSIS, 2000, 148 (02) : 209 - 214